XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note 15 - Equity-based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Notes Tables  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]

(in thousands, except years and per share data)

 

Awards

  

Weighted-

Average

Exercise

Price

  

Weighted-

Average

Remaining

Contractual

Life (years)

  

Aggregate

Intrinsic

Value

 

Outstanding at December 31, 2021

  4,449  $1.39   7.6  $460 

Options granted

  626  $0.28         

Restricted stock units granted

  180  $         

Restricted stock units vested

  (120

)

 $         

Options forfeited/cancelled

  (362

)

 $3.50         

Restricted stock units cancelled

  (30

)

 $         

Outstanding at September 30, 2022

  4,743  $1.07   7.8  $135 
                 

Vested and expected to vest at September 30, 2022

  3,492  $1.42   7.4  $20 
                 

Vested at September 30, 2022

  2,068  $2.06   6.3  $ 
                 

Exercisable at September 30, 2022

  2,068  $2.06   6.3  $ 
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Three Months Ended

September 30,

  

Nine Months Ended

September 30,

 
  

2022

  

2021

  

2022

  

2021

 

Research and development

 $5  $2  $14  $8 

Sales and marketing

  12   53   37   118 

General and administrative

  (225)  169   79   576 

Total stock-based compensation expense

 $(208) $224  $130  $702 
Employees and Directors [Member]  
Notes Tables  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

Nine Months Ended September 30,

 

Assumption

 

2022

  

2021

 

Expected price volatility

  158.04

%

  163.95

%

Expected term (in years)

  6.45   6.19 

Risk-free interest rate

  2.29

%

  0.92

%

Dividend yield

  0.00

%

  0.00

%

Weighted-average fair value of options granted during the period

 $0.27  $0.71